TY  - JOUR
T1  - Study of the Antitumor Activity of Selenium Nanoparticles
A1  - Arina Romanovna Maslyakova
A1  - Sabina Arturovna Magomedova
A1  - Islam Nazirovich Romantsov
A1  - Sharip Magomedrasulovich Nurbagandov
A1  - Mikhail Nikolaevich Bulovin
A1  - Oleg Rodionoviсh Podobin
JF  - Clinical Cancer Investigation Journal
JO  - Clin Cancer Investig J
SN  - 2278-0513
Y1  - 2023
VL  - 12
IS  - 1
DO  - 10.51847/yt84akUBr0
SP  - 43
EP  - 47
N2  - In the scientific literature, studies on the feasibility of using selenium nanoparticles in the development of pharmaceuticals are widely presented. The positive effects of selenium in the treatment of cancer, hepatitis C, thyroid disease, cardiovascular disease, asthma, and other diseases have been studied. This scientific paper presents the results of studies on the effect of selenium nanoparticles on the development of a cancerous tumor. The experiment was carried out on five groups of white laboratory mice, with group 1 (positive control) being healthy individuals; group 2 (negative control) - individuals infected with EPNT-5 cancer cells; group 3 (experiment) - infected individuals that received an injection of selenium nanoparticles; group 4 (experiment) - infected individuals that received an injection of selenium nanoparticles and immunoglobulin imG; group 5 (experiment) - infected individuals who received an injection of immunoglobulin imG. During the experiment, the development of the disease and the behavior of laboratory animals were monitored. After 4 weeks, blood was taken for a general and biochemical test, and the masses of the internal organs of laboratory mice were also examined.
UR  - https://ccij-online.org/article/study-of-the-antitumor-activity-of-selenium-nanoparticles-s7llorutvczpz9m
ER  -